SleeveSense is being developed as a wearable sleeve for continuous, automated monitoring of patients’ vital signs. Credit: SaiArLawKa2 / Shutterstock.com. Senphonix has received the US National ...
The test generates a ten-year risk estimate for five chronic conditions from a single blood sample. Credit: Nuttapong punna / Shutterstock.com. Nightingale Health and Genom have entered a partnership ...
The acquisition expands Labcorp’s presence in key clinical research regions. Credit: Gorodenkoff / Shutterstock.com. Labcorp has acquired MLM Medical Labs, expanding its worldwide central laboratory ...
The FDA’s clearance of Abbott’s TactiFlex Duo was based on data from the company’s FlexPulse IDE study. Credit: Michael Vi/Shutterstock.com The US Food and Drug Administration (FDA) has approved ...
De novo classification for Powerful Medical’s Queen of Hearts AI model follows breakthrough designation for its PMcardio platform in March 2025. Credit: Natykach Nataliia/Shutterstock.com The US Food ...
The trial participants are adults with moderate to severe OSA. Credit: daniiD / Shutterstock.com. Belgium-based medical technology company Nyxoah has implanted the first patient in BREATHE, its US ...
Aceso intends to make an IND filing with the FDA in 2027, teeing up clinical trials for ACT-101. Credit: Jo Panuwat D/Shutterstock.com Drug delivery specialist Aptar Pharma is collaborating with Aceso ...
OncoSil Medical expects a G-BA funded study, two European regulatory filings in the first half of FY27. Credit: Gorodenkoff / Shutterstock.com. Australian company OncoSil Medical, which develops ...
Brainomix’s AI-based quantitative lung imaging technology has been used to successfully detect therapeutic benefit in a clinical trial evaluating an experimental drug for a type of lung disease. The ...
The eV14-2v can be used with Philips Collaboration Live, which allows remote clinicians to view live images. Credit: Koninklijke Philips N.V. Philips has introduced the eV14-2v transvaginal transducer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results